Archives

by in
Entry Author Date Location
The Biotech IPO Phenomenon of 2013: Enjoy It While It Lasts 07/22/13 National
Alkermes Adds Cancer, MS Drugs To Growing Portfolio 07/17/13 Boston
While I Was Away on Denali: NanoString, Mirabilis, Seattle Genetics 07/03/13 Seattle
Constructing Innovation Supply Chains for the Pharmaceutical Industry 06/26/13 Boston
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study 05/15/13 San Francisco
Opexa Tries a Personalized Cell Therapy Against Last, Worst Stage of MS 05/02/13 Texas
Big Data Is BS in Healthcare. When Will It Become Real? 04/15/13 National
Boston Biotech Seizes the Momentum: The Photos 04/08/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
East Coast Biotech Roundup: Biogen Idec, Third Rock, T2 Bio, Dart 03/29/13 Boston
Biogen Idec Wins FDA Approval For Oral Multiple Sclerosis Drug 03/27/13 Boston
Allozyne Conducts Round of Employee ‘Furloughs’ 03/15/13 Seattle
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Someone Needs to Rank U.S. Biotech Hubs, For Real 03/04/13 National
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
East Coast Life Sciences Roundup: Biogen Idec, Celgene, Alnylam, More 02/08/13 Boston
Boston Roundup: Biogen Idec, Cloudant, NEA, eClinicalWorks, & More 02/06/13 Boston
Biogen ALS Failure Highlights Clinical Trial Frustrations 01/10/13 Boston
East Coast Life Sciences Roundup: Pfizer, J&J, Alkermes, More 01/04/13 Boston
Biogen Idec’s ALS Drug Fails Phase III Trial 01/03/13 Boston
Isis Pharmaceuticals Adds More Deals to Partnership Portfolio 12/12/12 San Diego
Tantalizing Hints of Progress Against ALS for Cytokinetics, Others 11/14/12 San Francisco
LinkedIn: The Quiet Force Transforming Biotech & Pharma 11/05/12 National
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Who Should Life Science Pros Follow on Twitter? 09/24/12 National
Biotech Begins to Come of Age on Twitter 09/17/12 National
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
IPOs, Biogen, Northeastern, & More From the Boston Life Sciences Roundup 08/17/12 Boston
San Diego Life Sciences Roundup: Regulus, MEI Pharma, Qualcomm & More 08/16/12 San Diego
Page 3 of 17 « previous page · next page »